Vermont docs received more secret payments

A March 2007 article in the Journal of the American Medical Association told the story of pharma companies paying physicians in Vermont over $2.7 million between July 2002 and June 2004, but the advocacy group that reported the original findings now says the amount is actually much higher.

According to the organization Public Citizen, the payments total nearly $5 million and "strongly suggest" violations of American Medical Association and PhRMA professional guidelines, which restrict said payments to $100 per doctor, per occassion.

In fact, the group found that more than $3.2 million worth of the payments were greater than $100 each, representing nearly 90 percent of the payments to physicians by drug companies. Twenty-one drugmakers were said to have kept the payments under wraps. The companies involved included Abbott Labs, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck and Roche. 

- see the full story at Pharmalot 

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.